Skip to main content
McKessonAcquisition

McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports

Source: Autobound Signal API · 48 signals tracked for McKesson · updated

Get McKesson's live signals in Claude or ChatGPT, or by API

AskWhat changed at McKesson this week? Use Autobound signals for mckesson.com.

What happened

McKesson and private equity firm Clayton Dubilier & Rice are nearing a deal to acquire infusion services provider Option Care Health in a transaction valued at more than $5 billion, including debt.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

By Sahil Pandey Oct 5 (Reuters) – Drug distributor McKesson and private equity firm Clayton Dubilier & Rice are nearing a deal to acquire infusion services ​provider Option Care Health in a ‌transaction valued at more than $5 billion including debt, the Financial Times reported on Monday, citing people familiar with the matter. Option Care's shares rose 21% in extended trading following ‌the ​report. The deal could be announced ⁠as soon as Tuesday, ⁠although talks could still fall apart, the report said. The possible acquisition would mark McKesson's latest deal as it seeks to expand its healthcare ​services footprint. In August, the company agreed to buy Precision Medicine Group for about $2.25 billion ⁠as part of a years-long ⁠effort to strengthen higher-growth businesses. Leerink Partners ​analyst Michael Cherny said the "strategic rationale" for a deal ​made sense, as it would expand McKesson's reach ‌beyond physician offices into home and alternate-site care settings. Option Care provides infusion services that allow patients to receive intravenous medications at home or in ⁠other outpatient settings rather than in hospitals. McKesson had been reshaping its portfolio by exiting non-core assets and investing ⁠in areas ‌such as oncology and specialty care. Revenue ⁠in its oncology & multispecialty segment rose ​33% ‌in the latest reported quarter, helped ​by growth ⁠in...

Keep reading with a free account

The rest of this article, and every signal for McKesson, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Acquisition

What this signalsIntegration work after a deal often opens needs for new systems and services.

Amount
$5B
Takes effect
Oct 6, 2026

Companies

  • Option Care HealthTargetoptioncarehealth.com

More acquisition signals at other companies

The full record

From the Signal API record

Numbers

Amount (USD)
$5B

Extraction

Confidence
90%
Detected
Oct 5, 2026
signal_type
news
signal_subtype
acquires

Use this data

Get every acquisition signal for McKesson and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at McKesson this week?”

  2. Send it to your own tools

    The Signal API returns acquisition signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/41f41187-a61c-4d61-80b4-e62304af1c2f returns this record as JSON. POST /v1/companies/enrich returns every signal for mckesson.com.

{
  "signal_id": "41f41187-a61c-4d61-80b4-e62304af1c2f",
  "signal_type": "news",
  "signal_subtype": "acquires",
  "detected_at": "2026-10-05T23:54:39+00:00",
  "company": {
    "name": "McKesson",
    "domain": "mckesson.com"
  },
  "data": {
    "url": "https://wixx.com/2026/10/05/mckesson-cdr-near-5-billion-plus-deal-to-buy-option-care-ft-reports/",
    "title": "McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports - wixx.com",
    "excerpt": "By Sahil Pandey Oct 5 (Reuters) – Drug distributor McKesson and private equity firm Clayton Dubilier & Rice are nearing a deal to acquire infusion services ​provider Option Care Health in a ‌transaction valued at more than $5 billion including debt, the Financial Times reported on Monday, citing people familiar with the matter. Option Care’s shares rose 21% in extended trading following ‌the ​report. The deal could be announced ⁠as soon as Tuesday, ⁠although talks could still fall apart, the report said. The possible acquisition would mark McKesson’s latest deal as it seeks to expand its healthcare ​services footprint. In August, the company agreed to buy Precision Medicine Group for about $2.25 billion ⁠as part of a years-long ⁠effort to strengthen higher-growth businesses. Leerink Partners ​analyst Michael Cherny said the “strategic rationale” for a deal ​made sense, as it would expand McKesson’s reach ‌beyond physician offices into home and alternate-site care settings. Option Care provides infusion services that allow patients to receive intravenous medications at home or in ⁠other outpatient settings rather than in hospitals. McKesson had been reshaping its portfolio by exiting non-core assets and investing ⁠in areas ‌such as oncology and specialty care. Revenue ⁠in its oncology & multispecialty segment rose ​33% ‌in the latest reported quarter, helped ​by growth ⁠in...",
    "summary": "McKesson and private equity firm Clayton Dubilier & Rice are nearing a deal to acquire infusion services provider Option Care Health in a transaction valued at more than $5 billion, including debt.",
    "planning": true,
    "image_url": "https://media-cdn.socastsrm.com/uploads/station/2169/fbShare.png?r=59012",
    "confidence": 0.9,
    "published_at": "2026-10-05T23:54:39Z",
    "effective_date": "2026-10-06",
    "article_sentence": "Drug distributor McKesson and private equity firm Clayton Dubilier & Rice are nearing a deal to acquire infusion services ​provider Option Care Health in a ‌transaction valued at more than $5 billion including debt, the Financial Times reported on Monday, citing people familiar with the matter.",
    "amount_normalized": 5000000000,
    "related_company_name": "Option Care Health",
    "related_company_domain": "optioncarehealth.com"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.